Clones: 1G8.1, 2E11, 3E3.1, and GAM2.1 (BBP2020SP, BBP2019SP, BBP2018SP, and BBP2021SP respectively)  Monoclonal antibodies against IFN-gamma. Preliminary experiments show clones 2E11 and 3E3.1 may function to neutralize IFN gamma. IFN-gamma is produced by lymphocytes activated by specific antigens or mitogens. In addition to having antiviral activity, IFN-gamma has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons.

 

Trial Pack of Four Interferon Gamma Monoclonal Antibodies, Size: 25 µg each

SKU: BBPTP0001
$275.00Price
  • Tested Applications:  ELISA/WESTERN, Preliminary experiments show clones 2E11 and 3E3.1 may function to neutralize IFN gamma.

     

    Target Information:  Interferon gamma is a 19.22kDa immuno-regulatory cytokine.

     

    Product Format:  Affinity Purified, 1 mg/ml in Phosphate Buffered Saline. Aseptically Packaged.

     

    Alternate Names:  Interferon gamma, IFN gamma

     

    Clones:  1G8.1, 2E11, 3E3.1, GAM2.1

     

    Host:  Mouse

     

    Isotype:  IgG1

     

    Immunogen:  Recombinant Protein

     

    Specificity:  Human IFN-gamma

  • This product contains the equivalent of trial sizes of Neoclone Catalog #s N0009, N0010, N0011, and N0012 or BioLegend Catalog #s 526502, 526602, 526702, and 526802.

©2018 by AdvantiGen Biosciences.

Fluorescent Photos Courtesy of Beach Laboratory.